Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice

被引:0
|
作者
Melisa J. Hamilton
Judit P. Banáth
Vivian Lam
Nancy E. LePard
Gerald Krystal
Kevin L. Bennewith
机构
[1] British Columbia Cancer Agency Research Centre,Terry Fox Laboratory
[2] British Columbia Cancer Agency Research Centre,Department of Integrative Oncology
[3] British Columbia Cancer Agency Research Centre,Department of Integrative Oncology
来源
Cancer Immunology, Immunotherapy | 2012年 / 61卷
关键词
Myeloid-derived suppressor cells (MDSCs); Immune suppression; 4T1 tumor cells; Serum; Albumin;
D O I
暂无
中图分类号
学科分类号
摘要
As more groups investigate the role of myeloid-derived suppressor cells (MDSCs) in promoting the growth of primary tumors and distant tumor metastases, it is imperative to ensure the accurate detection and quantification of MDSC immunosuppression ex vivo. MDSCs are defined by their ability to suppress immune responses. Although different in vitro culture conditions have been used to study MDSCs, the effect of different culture conditions on MDSC immunosuppression is unknown. We therefore isolated MDSCs from the lungs and spleens of 4T1 murine mammary tumor-bearing mice and assayed MDSC-mediated suppression of T cell responses under different culture conditions. We found that 4T1-induced MDSCs effectively suppressed T cell proliferation under serum-free conditions, but not when fetal calf serum (FCS) was present. FCS neither altered the immunosuppressive activities of other myeloid cell types (i.e., peritoneal or tumor-associated macrophages) nor modified the susceptibility of T cells to myeloid cell-mediated suppression, but instead acted directly on 4T1-induced MDSCs to significantly reduce their immunosuppressive function. Importantly, we found that bovine serum albumin was a major contributor to the antagonistic effects of FCS on 4T1-induced MDSC immunosuppression by inhibiting reactive oxygen species production from MDSCs. This work reveals that in vitro culture conditions influence the immunosuppressive properties of MDSCs and highlights the importance of testing different culture conditions on MDSC phenotype to ensure that MDSC immunosuppression is not being masked. These data have important implications for the accurate detection and identification of MDSCs, as well as for determining the influence of MDSC-mediated immunosuppression on primary and metastatic tumor growth.
引用
收藏
页码:643 / 654
页数:11
相关论文
共 50 条
  • [11] CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
    Zoglmeier, Christine
    Bauer, Helen
    Noerenberg, Daniel
    Wedekind, Georg
    Bittner, Philipp
    Sandholzer, Nadja
    Rapp, Moritz
    Anz, David
    Endres, Stefan
    Bourquin, Carole
    CLINICAL CANCER RESEARCH, 2011, 17 (07) : 1765 - 1775
  • [12] Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs
    Hlavaty, Sabina I.
    Chang, Yu-Mei
    Orth, Rachel P.
    Goulian, Mark
    Planet, Paul J.
    Thamm, Douglas H.
    Punt, Jennifer A.
    Garden, Oliver A.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [13] TRAF6 Regulates the Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Tumor-Bearing Host
    Song, Ge
    Zhang, Yue
    Tian, Jie
    Ma, Jie
    Yin, Kai
    Xu, Huaxi
    Wang, Shengjun
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [14] Expression of PD-1 protein on the surface of myeloid-derived suppressor cells (MDSCs) derived from tumor-bearing mice
    Nam, S.
    Lee, A.
    Lim, J.
    Lim, J.
    FEBS OPEN BIO, 2019, 9 : 353 - 353
  • [15] Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
    Hong Qin
    Beatrisa Lerman
    Ippei Sakamaki
    Guowei Wei
    Soungchul C Cha
    Sheetal S Rao
    Jianfei Qian
    Yared Hailemichael
    Roza Nurieva
    Karen C Dwyer
    Johannes Roth
    Qing Yi
    Willem W Overwijk
    Larry W Kwak
    Nature Medicine, 2014, 20 : 676 - 681
  • [16] Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
    Sawanobori, Yasushi
    Ueha, Satoshi
    Kurachi, Makoto
    Shimaoka, Takeshi
    Talmadge, James E.
    Abe, Jun
    Shono, Yusuke
    Kitabatake, Masahiro
    Kakimi, Kazuhiro
    Mukaida, Naofumi
    Matsushima, Kouji
    BLOOD, 2008, 111 (12) : 5457 - 5466
  • [17] Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
    Qin, Hong
    Lerman, Beatrisa
    Sakamaki, Ippei
    Wei, Guowei
    Cha, Soungchul C.
    Rao, Sheetal S.
    Qian, Jianfei
    Hailemichael, Yared
    Nurieva, Roza
    Dwyer, Karen C.
    Roth, Johannes
    Yi, Qing
    Overwijk, Willem W.
    Kwak, Larry W.
    NATURE MEDICINE, 2014, 20 (06) : 676 - 681
  • [18] Polysaccharide from Lentinus edodes Inhibits the Immunosuppressive Function of Myeloid-Derived Suppressor Cells
    Wu, Hao
    Tao, Ning
    Liu, Xiaoman
    Li, Xiao
    Tang, Jian
    Ma, Chungwah
    Xu, Xiaofei
    Shao, Haitao
    Hou, Baidong
    Wang, Hui
    Qin, Zhihai
    PLOS ONE, 2012, 7 (12):
  • [19] Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
    Mundy-Bosse, Bethany L.
    Lesinski, Gregory B.
    Jaime-Ramirez, Alena C.
    Benninger, Kristen
    Khan, Mahmood
    Kuppusamy, Periannan
    Guenterberg, Kristan
    Kondadasula, Sri Vidya
    Chaudhury, Abhik Ray
    La Perle, Krista M.
    Kreiner, Melanie
    Young, Gregory
    Guttridge, Denis C.
    Carson, William E., III
    CANCER RESEARCH, 2011, 71 (15) : 5101 - 5110
  • [20] Baccatin III, a precursor for the semisynthesis of paclitaxel, inhibits the accumulation and suppressive activity of myeloid-derived suppressor cells in tumor-bearing mice
    Lee, Young-Hee
    Lee, Young-Ran
    Park, Chan-Su
    Im, Sun-A
    Song, Sukgil
    Hong, Jin Tae
    Whang, Bang Yeon
    Kim, Kyungjae
    Lee, Chong-Kil
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (02) : 487 - 493